Nevirapine

Sold as Cipla nevirapine, Aspen nevirapine, Bio-nevirapine, Adco-nevirapine, Bindopin, Nevivir, Nevimune for, Macleods nevirapine, Nevirapine viatris, Nevirapine litha, Nepraz, Vari-nevirapine, Sonke-nevirapine, Viropon

C₁₅H₁₄N₄O266.30 g/mol

2-Cyclopropyl-7-methyl-2,4,9,15-tetrazatricyclo[9.4.0.03,8]pentadeca-1(11),3,5,7,12,14-hexaen-10-one

Drag to rotate. Structure from PubChem CID 4463.

Loading Wikipedia summary

Registration

Applicants: 13
Registrations: 19
Schedule source: Consolidated Schedules 06 July 2026

Applicants and registrations

Applicant	Brands	Dosages	Registrations	Schedule	Leaflets
Cipla Medpro (Pty) LtdCancelled	Cipla nevirapine, Nevimune for	50 mg, 100 mg	360423, 450817, 450818	S4	None
Pharmacare limited û woodmead	Aspen nevirapine	200 mg, suspension	380240, A390262	S4	None
Biotech Laboratories (Pty) Ltd	Bio-nevirapine	200	410230	S4	None
Adcock ingram limited	Adco-nevirapine	tablets	410235	S4	None
Aurobindo Pharma (Pty) Ltd1 of 2 cancelled	Bindopin	50 mg/5 ml, 200 mg	420466, 430287	S4	None
Hetero Drugs South Africa (Pty) Ltd	Nevivir	Not stated	430230	S4	None
Macleods Pharmaceuticals SA (Pty) Ltd	Macleods nevirapine	200 mg	450886	S4	PI PIL
Viatris Healthcare (Pty) Ltd	Nevirapine viatris	200 mg	460005	S4	None
Acino Pharma (Pty) Ltd	Nevirapine litha, Nepraz	Not stated	480028, 480029	S4	None
Cipla Medpro Manufacturing (Pty) Ltd	Cipla nevirapine	oral suspension	A380339	S4	None
Lebasi Pharmaceuticals (Pty) LtdCancelled	Vari-nevirapine	200 mg	A390112	S4	None
Ranbaxy (SA) (Pty) LtdCancelled	Sonke-nevirapine	tablets	A400341	S4	None
Novagen Pharma (Pty) Ltd1 of 2 cancelled	Viropon	50 mg/5 ml, 200 mg	A400382, A400490	S4	None

Variants

Product	Strength and form	Registration	Status	Schedule	Leaflets
Cipla nevirapine EACH TABLET CONTAINS NEVIRAPINE 200,0 mg	Not listed	36042336/20.2.8/0423	Cancelled	S4	None
Aspen nevirapine 200 MG EACH TABLET CONTAINS NEVIRAPINE 200,0 mg	200 mg	38024038/20.2.8/0240	Registered	S4	None
Bio-nevirapine 200 EACH TABLET CONTAINS NEVIRAPINE 200,0 mg	200	41023041/20.2.8/0230	Registered	S4	None
Adco-nevirapine tablets EACH TABLET CONTAINS :NEVIRAPINE 200,0 mg	Tablets	41023541/20.2.8/0235	Registered	S4	None
Bindopin tablets 200 MG EACH TABLET CONTAINS NEVIRAPINE 200,0 mg	200 mgTablets	42046642/20.2.8/0466	Cancelled	S4	None
Nevivir EACH TABLET CONTAINS NEVIRAPINE 200,0 mg	Not listed	43023043/20.2.8/0230	Registered	S4	None
Bindopin suspension 50 mg/5 ML EACH 5,0 ml SUSPENSION CONTAINS NEVIRAPINE 50,0 mg	50 mg/5 mlSuspension	43028743/20.2.8/0287	Registered	S4	None
Nevimune 50 MG tablets for oral suspension EACH TABLET CONTAINS NEVIRAPINE 50,0 mg	50 mgTablets oral suspension	45081745/20.2.8/0817	Cancelled	S4	None
Nevimune 100 MG tablets for oral suspension EACH TABLET CONTAINS NEVIRAPINE 100,0 mg	100 mgTablets oral suspension	45081845/20.2.8/0818	Cancelled	S4	None
Macleods nevirapine 200 EACH TABLET CONTAINS NEVIRAPINE 200,0 mg	200 mgTablets	45088645/20.2.8/0886Approved 23 May 2025	Registered	S4	PI PIL
Nevirapine 200 MG viatris EACH TABLET CONTAINS NEVIRAPINE 200,0 mg	200 mg	46000546/20.2.8/0005	Registered	S4	None
Nevirapine litha EACH TABLET CONTAINS NEVIRAPINE 200,0 mg	Not listed	48002848/20.2.8/0028	Registered	S4	None
Nepraz EACH TABLET CONTAINS NEVIRAPINE 200,0 mg	Not listed	48002948/20.2.8/0029	Registered	S4	None
Cipla nevirapine oral suspension EACH 5,0 ml SUSPENSION CONTAINS NEVIRAPINE 50,0 mg	Oral suspension	A380339A38/20.2.8/0339	Registered	S4	None
Vari-nevirapine 200 MG EACH TABLET CONTAINS NEVIRAPINE 200,0 mg	200 mg	A390112A39/20.2.8/0112	Cancelled	S4	None
Aspen nevirapine suspension EACH 5,0 ml SUSPENSION CONTAINS NEVIRAPINE 50,0 mg	Suspension	A390262A39/20.2.8/0262	Registered	S4	None
Sonke-nevirapine tablets EACH TABLET CONTAINS NEVIRAPINE 200,0 mg	Tablets	A400341A40/20.2.8/0341	Cancelled	S4	None
Viropon 200 MG tablets EACH TABLET CONTAINS NEVIRAPINE 200,0 mg	200 mgTablets	A400382A40/20.2.8/0382	Registered	S4	None
Viropon 50 mg/5 ML oral suspension EACH 5,0 ml SUSPENSION CONTAINS NEVIRAPINE 50,0 mg	50 mg/5 mlOral suspension	A400490A40/20.2.8/0490	Cancelled	S4	None

Regulatory status

Where S4 sits on the scale

S0S1S2S3S4S5S6S7S8

Prescription-only medicine.

Schedule 4 covers most ordinary prescription medicines. You need a prescription from an authorised prescriber, such as a doctor or dentist, and a pharmacist dispenses it. Its price, name, pack size and strength can still be told to the public, as long as nothing links it to what it treats.

Schedule S4, matched to the Consolidated Schedules by ingredient, confidence high.

Who may supply: A pharmacist dispensing against a written or verbal prescription from an authorised prescriber; a veterinarian, who may also prescribe, compound or dispense it directly; a medical practitioner or dentist, who may prescribe it and may compound or dispense it directly only if licensed under section 22C(1)(a); manufacturers and wholesalers may supply people who may lawfully possess it; and, for animal treatment, a person practising a para-veterinary profession, on a veterinarian's written or verbal instruction.

Consolidated Schedules listings for Nevirapine

S4: Nevirapine
Consolidated Schedules 06 July 2026, line 7245

Pharmacological class: Antiviral agents. (class 20.2.8)

This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.

SAHPRA documents

Schedule verified from official documents

Schedule Verification

Macleods nevirapine 200, Macleods Pharmaceuticals SA (Pty) Ltd is scheduled S4 in its official SAHPRA documents, read with 90% confidence.

Professional information (PI)For healthcare professionalsMacleods nevirapine 200, Macleods Pharmaceuticals SA (Pty) Ltd Patient information leaflet (PIL)For patients and carersMacleods nevirapine 200, Macleods Pharmaceuticals SA (Pty) Ltd

These documents are provided by SAHPRA for informational purposes. Always consult with a healthcare professional for medical advice.

Research articles

Loading PubMed articles

Background